Stockscreener 앱 받기
11.01
1.76%
0.19
시간 외 거래:
10.63
-0.38
-3.45%
전일 마감가:
$10.82
열려 있는:
$10.99
하루 거래량:
2.79M
Relative Volume:
1.55
시가총액:
$618.05M
수익:
$27.46M
순이익/손실:
$-46.05M
주가수익비율:
-8.5349
EPS:
-1.29
순현금흐름:
$-33.83M
1주 성능:
+12.92%
1개월 성능:
+37.97%
6개월 성능:
+67.84%
1년 성능:
+39.02%
1일 변동 폭
$10.36
$11.18
1주일 범위
$9.55
$11.23
52주 변동 폭
$6.19
$13.16
Zevra Therapeutics Inc Stock (ZVRA) Company Profile
명칭
Zevra Therapeutics Inc
전화
(321) 939-3416
주소
1180 CELEBRATION BOULEVARD, SUITE 103, CELEBRATION
ZVRA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ZVRA
Zevra Therapeutics Inc
|
11.01 | 607.38M | 27.46M | -46.05M | -33.83M | -1.29 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.79 | 106.37B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
460.46 | 59.90B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
564.63 | 60.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
796.92 | 49.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.10 | 36.88B | 4.56B | -176.77M | 225.30M | -1.7177 |
Zevra Therapeutics Inc Stock (ZVRA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-02 | 개시 | H.C. Wainwright | Buy |
| 2025-01-08 | 재개 | Cantor Fitzgerald | Overweight |
| 2024-10-07 | 개시 | Guggenheim | Buy |
| 2024-09-24 | 개시 | JMP Securities | Mkt Outperform |
| 2024-09-24 | 재확인 | Maxim Group | Buy |
| 2024-04-02 | 재확인 | Maxim Group | Buy |
| 2024-03-12 | 개시 | William Blair | Outperform |
| 2023-03-17 | 개시 | Maxim Group | Buy |
모두보기
Zevra Therapeutics Inc 주식(ZVRA)의 최신 뉴스
Can Zevra Therapeutics Inc. (1GDA) stock sustain breakout momentumDip Buying & Stepwise Trade Signal Implementation - newser.com
How moving averages guide Zevra Therapeutics Inc. tradingJuly 2025 Summary & Stock Timing and Entry Methods - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock test record highs in 2025Trade Risk Report & AI Enhanced Trade Execution Alerts - newser.com
Chart overlay techniques for tracking Zevra Therapeutics Inc.July 2025 Setups & Daily Stock Trend Watchlist - newser.com
What moving averages say about Zevra Therapeutics Inc.2025 Valuation Update & Fast Exit/Entry Strategy Plans - newser.com
Zevra Therapeutics (ZVRA): Evaluating Valuation Following Insider Buying and Sustained Revenue Growth - Yahoo
Zevra Therapeutics gains amid takeover speculation - MSN
What to do if you’re stuck in Zevra Therapeutics Inc.Market Risk Summary & Expert Verified Movement Alerts - newser.com
Why global investors buy Zevra Therapeutics Inc. (1GDA) stock2025 Key Highlights & AI Enhanced Trading Signals - newser.com
Using RSI to spot recovery in Zevra Therapeutics Inc.Earnings Risk Report & Long-Term Investment Growth Plans - newser.com
What drives Zevra Therapeutics Inc stock priceBearish Engulfing Patterns & Breakout Portfolio Performance - earlytimes.in
What drives Zevra Therapeutics Inc 1GDA stock priceEx-Dividend Date Alerts & Affordable Market Growth - earlytimes.in
The Three-year Returns Have Been Decent for Zevra Therapeutics (NASDAQ:ZVRA) Shareholders Despite Underlying Losses Increasing - 富途牛牛
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Zevra Therapeutics (NASDAQ:ZVRA) Sees Unusually-High Trading VolumeShould You Buy? - MarketBeat
Zevra Therapeutics' Stock Soars on Strong Performance and Strategic Wins: What It Means for Investors - FinancialContent
Will Zevra Therapeutics Inc. rebound enough to break evenMarket Weekly Review & Weekly High Conviction Ideas - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a top dividend aristocrat candidateInflation Watch & Free Risk Controlled Daily Trade Plans - newser.com
Will Zevra Therapeutics Inc. (1GDA) stock benefit from Fed rate cutsCPI Data & Community Consensus Stock Picks - newser.com
Is Zevra Therapeutics Inc. (1GDA) stock a buy for dividend portfoliosJuly 2025 Selloffs & Precise Swing Trade Alerts - newser.com
Visual trend scoring systems applied to Zevra Therapeutics Inc.2025 Major Catalysts & Fast Gain Stock Tips - newser.com
How to use a screener to detect Zevra Therapeutics Inc. breakoutsQuarterly Market Summary & High Accuracy Swing Entry Alerts - newser.com
Zevra Therapeutics (NASDAQ:ZVRA) Rating Lowered to Hold at Wall Street Zen - Defense World
Will Zevra Therapeutics Inc. (1GDA) stock draw ESG focused funds2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
Can trapped investors hope for a rebound in Zevra Therapeutics Inc.Trade Volume Report & Weekly Setup with ROI Potential - newser.com
How Zevra Therapeutics Inc. (1GDA) stock trades in high volatilityJuly 2025 Institutional & Low Risk Entry Point Tips - newser.com
How Investors May Respond To Zevra Therapeutics (ZVRA) European Review of MIPLYFFA for Rare Disease Expansion - Sahm
How institutional ownership impacts Zevra Therapeutics Inc. stockEarnings Overview Summary & Smart Money Movement Alerts - newser.com
Daily Brief United States: Rocket Lab USA , Northwest Biotherapeutics, Fermi, Occidental Petroleum, Intel Corp, Zevra Therapeutics , UP Fintech, Rogers Corp, Rollins Inc, Lockheed Martin and more - Smartkarma
Zevra Therapeutics (NASDAQ:ZVRA) Shares Gap DownWhat's Next? - MarketBeat
Is Zevra Therapeutics Inc. trending in predictive chart modelsWeekly Trade Analysis & Technical Buy Zone Confirmations - newser.com
Zevra Therapeutics Inc (ZVRA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
5.74%
자본화:
|
볼륨(24시간):